Biomarker Testing During Pregnancy: When, How, and Why Not

Join the ACC Cardio-Obstetrics Work Group for a discussion highlighting the recent article The Utilization and Interpretation of Cardiac Biomarkers During Pregnancy: JACC: Advances Expert Panel.

During this webinar we will discuss trends in cardiac biomarkers during pregnancy and after delivery in normal pregnancies as well as in specific disease states like preeclampsia, peripartum cardiomyopathy, and congenital heart disease. We will address when biomarker testing may be helpful and how to interpret abnormal values in the peripartum period. Multidisciplinary Q&A session with cardiologist and obstetrician panelists will allow for discussion on the nuances of biomarker changes during pregnancy and expert opinion on best practices for biomarker testing.

The target audience includes general cardiologists, obstetricians, and other healthcare team members with an interest in cardio-obstetrics.

As always, please read the article ahead of time. Bring your questions and participate in a live Q&A session with the article authors and expert panelists.

The Utilization and Interpretation of Cardiac Biomarkers During Pregnancy: JACC: Advances Expert Panel

Speakers:
Malamo E. Countouris, MD
Katharine E. Economy, MD
Amy A. Sarma, MD
Nandita S. Scott, MD

Clinical Topics: Congenital Heart Disease and Pediatric Cardiology, Heart Failure and Cardiomyopathies

Keywords: